ロード中...
Phase II Study of Daily Sunitinib in FDG-PET Positive, Iodine Refractory, Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of Thyroid with Functional Imaging Correlation
PURPOSE: We conducted a phase II study to assess the efficacy of continuous dosing of sunitinib in patients with FDG-PET avid, iodine refractory, well-differentiated thyroid carcinoma (WDTC) and medullary thyroid cancer (MTC), and to assess for early response per FDG-PET. EXPERIMENTAL DESIGN: Patien...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3063514/ https://ncbi.nlm.nih.gov/pubmed/20847059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0994 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|